Clinical trials recruiting in Hanzhou, China

Phase breakdown

Conditions recruiting in Hanzhou, China

Recruiting trials in Hanzhou, China

• Application of Radiomics in Breast Cancer
  NCT04483804 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Circulating Tumor DNA Methylation Guiding Postoperative Adjuvant Chemotherapy in Stage III Colorectal Cancer
  NCT06167967 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
  NCT05899608 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
  NCT05212454 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female
• JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
  NCT06079983 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
  NCT04778839 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• The Hi-tACS on Cognitive Function in Patients With Schizophrenia
  NCT06470516 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Hanzhou, China?

7 recruiting trials have at least one study site in Hanzhou, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.